Skip to main content
Wanbury Limited logo

Wanbury Limited — Investor Relations & Filings

Ticker · WANBURY ISIN · INE107F01022 LEI · 335800QB384KGMBID276 BSE.NS Manufacturing
Open in API
Filings indexed 916 across all filing types
Latest filing 2019-11-05 Regulatory Filings
Country IN India
Listing BSE.NS WANBURY

About Wanbury Limited

https://www.wanbury.com

Wanbury Limited specializes in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and finished formulations. The organization maintains a significant global presence, particularly as a leading producer of Metformin. Its product portfolio spans diverse therapeutic areas, including gynecology, orthopedics, hematinics, and anti-diabetics. The company operates manufacturing facilities compliant with international regulatory standards, including the USFDA. Wanbury focuses on providing medicinal solutions through integrated research and development capabilities and large-scale production infrastructure, serving both domestic and international markets with a range of specialty products.

Recent filings

Filing Released Lang Actions
WANBURY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2019 ,inter alia, to consider and approve Notice is hereby given pursuant to ....
Regulatory Filings
2019-11-05 English
Updates
Regulatory Filings Classification · 100% confidence The document text contains only placeholders for images and no substantive text content. The true document length is only 279 characters, which is very short and does not contain any financial data, report content, or announcements. It appears to be a non-informative or placeholder document without any report or announcement details. Given the lack of content and the short length, this document does not qualify as any specific report or announcement type. According to the rules, such documents fall under the fallback category of Regulatory Filings (RNS).
2019-11-01 English
In compliance with the provisions of Regulation 47(1)(d) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations'), ...
Regulatory Filings
2019-11-01 English
Preferential issue
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a detailed notice regarding the dispatch of a Postal Ballot Notice to shareholders of Wanbury Limited. It references the Companies Act, 2013, SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, and SEBI ICDR Regulations. The document includes the text of the Postal Ballot Notice, explanatory statements, and the special resolution to be passed by shareholders via postal ballot. The resolution concerns the issue and allotment of equity shares on a preferential basis as part of debt restructuring. The document is not a report of voting results but the notice and materials sent to shareholders to inform and solicit their votes. It is not an announcement of a report publication, nor a management or financial report. Therefore, it fits the category of Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings or resolutions.
2019-10-30 English
Sub.: ¬Intimation of Dispatch of Postal Ballot Notice We hereby inform you that pursuant to Section 110 of the Companies Act, 2013 read with Rule 22 of Companies (Management and Administration) ....
Regulatory Filings
2019-10-30 English
Outcome of Board Meeting
Regulatory Filings
2019-10-22 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.